These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16517902)

  • 1. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
    Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
    J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
    Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
    J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array.
    Liu H; Mao R; Fan L; Xia J; Li Y; Yin Y; Li X; Zhao X; Guo H; Zhu H; Zhang Y; Kang Y; Zhang J
    J Virol Methods; 2011 Jul; 175(1):1-6. PubMed ID: 21513743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.
    Ozekinci T; Mese S; Ozbek E; Atmaca S
    Clin Ter; 2014; 165(1):13-7. PubMed ID: 24589944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
    Zaaijer HL; Takkenberg RB; Weegink CJ; Rebers SP; Menting S; Reesink HW; Schinkel J; Molenkamp R
    J Med Virol; 2009 Mar; 81(3):413-6. PubMed ID: 19152408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
    Lupo J; Larrat S; Hilleret MN; Germi R; Boyer V; Nicod S; Barguès G; Leroy V; Seigneurin JM; Zarski JP; Morand P
    J Virol Methods; 2009 Mar; 156(1-2):52-8. PubMed ID: 19041345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
    Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
    Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.
    Corsa AC; Liu Y; Flaherty JF; Mitchell B; Fung SK; Gane E; Miller MD; Kitrinos KM
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
    Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
    J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant of hepatitis B virus with primary resistance to adefovir.
    Schildgen O; Sirma H; Funk A; Olotu C; Wend UC; Hartmann H; Helm M; Rockstroh JK; Willems WR; Will H; Gerlich WH
    N Engl J Med; 2006 Apr; 354(17):1807-12. PubMed ID: 16641397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
    Arslan U; Ural O; Findik D
    Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adefovir for lamivudine resistant HBV: more than meets the eye.
    Di Marco V; Craxì A
    J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
    Libbrecht E; Doutreloigne J; Van De Velde H; Yuen MF; Lai CL; Shapiro F; Sablon E
    J Clin Microbiol; 2007 Dec; 45(12):3935-41. PubMed ID: 17913933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.
    Vincenti D; Piselli P; Solmone M; D'Offizi G; Capobianchi MR; Menzo S
    Antiviral Res; 2017 Jul; 143():62-68. PubMed ID: 28322924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
    Su F; Dai J; Yang S; Jiang X; Cui X; Ning H; Li J; Huang M
    J Med Virol; 2015 Sep; 87(9):1527-31. PubMed ID: 26032700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy.
    Chang UI; Lee YC; Wie SH; Jang JW; Bae SH; Choi JY; Yang JM; Yoon SK; Sun HS
    J Med Virol; 2007 Jul; 79(7):902-10. PubMed ID: 17516533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
    Alagozlu H; Ozdemir O; Koksal B; Yilmaz A; Coskun M
    Asian Pac J Cancer Prev; 2013; 14(9):5489-94. PubMed ID: 24175847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to adefovir depends on mutation patterns in precore region, basal core promoter and reverse transcriptase, and on-treatment responses in Lamivudine-resistant chronic hepatitis B patients.
    Song BC; Cui XJ; Shin JW; Park NH; Cho YK; Song HJ; Hyun S; Jeong SU; Choi EK; Kim HU
    Intervirology; 2010; 53(4):203-10. PubMed ID: 20332649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.